2025-07-29 - Analysis Report
Okay, here's a comprehensive analysis of Nike Inc. (NKE) based on the provided data, formatted as requested.

**Report: Nike Inc. (NKE) Analysis**

**Company Overview:** Nike Inc. is a global leader in athletic footwear, apparel, equipment, and accessories.

**1. Performance vs. S&P 500 (VOO) & Alpha/Beta Analysis**

*   **Key Numbers:**
    *   NKE Cumulative Return: 3.86%
    *   VOO Cumulative Return: 99.63%
    *   Divergence: -96.7% (Relative Divergence: 0.0)

*   **Analysis:**
    Nike's cumulative return significantly underperforms the S&P 500 (VOO) by a substantial margin (-96.7%). The relative divergence of 0.0 indicates NKE is at the lowest end of its historical divergence range compared to VOO. This suggests significant underperformance relative to the broader market during the observed period.

*   **Alpha, Beta Analysis**

| Year       | CAGR  | MDD   | Alpha  | Beta  | Cap(B) |
| :----------- | :----- | :----- | :------ | :----- | :------ |
| 2015-2017  | 18.0% | 59.1% | -11.0% | 0.1  | 92.4   |
| 2016-2018  | 1.0%  | 12.5% | -17.0% | 0.2  | 109.5  |
| 2017-2019  | 57.0% | 12.5% | 28.0%  | 0.6  | 149.6  |
| 2018-2020  | 68.0% | 59.8% | 48.0%  | 0.7  | 208.9  |
| 2019-2021  | 75.0% | 59.8% | 27.0%  | 0.7  | 246.2  |
| 2020-2022  | 0.0%  | 73.8% | -2.0%  | 0.8  | 172.8  |
| 2021-2023  | -30.0% | 73.8% | -48.0% | 1.2  | 160.3  |
| 2022-2024  | -74.0% | 73.8% | -99.0% | 1.8  | 111.8  |
| 2023-2025  | -52.0% | 83.7% | -103.0% | -0.5 | 117.0  |

*   **Analysis:**
    *   **CAGR (Compound Annual Growth Rate):** The CAGR shows significant fluctuations, with strong growth in the 2017-2021 period but sharp declines in the more recent years (2021-2025).
    *   **MDD (Maximum Drawdown):** The MDD figures indicate substantial risk, especially in recent periods (2020-2025), with high drawdown percentages.
    *   **Alpha:** Alpha is consistently negative in recent years, indicating underperformance relative to the benchmark.
    *   **Beta:** Beta values are generally positive, suggesting the stock tends to move in the same direction as the market, but the negative beta in 2023-2025 indicates an inverse relationship. Beta increased significantly in 2022-2024 indicating higher volatility than market.
    *   **Cap(B):** Market capitalization has varied, reflecting market sentiment and business performance.

**2. Recent Stock Price Movements**

*   **Key Numbers:**
    *   Current Price: $79.24
    *   Previous Close: $76.27
    *   Change: 3.89
    *   5-day Moving Average: $76.61
    *   20-day Moving Average: $74.37
    *   60-day Moving Average: $65.68

*   **Analysis:**
    The stock price shows a recent increase, closing at $79.24 with a significant change of 3.89. The current price is above the 5-day, 20-day, and 60-day moving averages, suggesting a short-term upward trend. The significant price increase reflects a recent positive shift, likely driven by the 'change' metric.

**3. RSI, PPO, and Expected Return Analysis**

*   **Key Numbers:**
    *   Market Risk Indicator (MRI): 0.3286 (Low Risk)
    *   RSI: 67.76
    *   PPO: 0.0759
    *   Hybrid Signal: cash_7%_Buy 90% of cash (1030 shares - Safe - MRI:0.33)
    *   20-day Relative Divergence Change: -0.5 (Short-term decrease)
    *   Expected Return: -2182%

*   **Analysis:**
    *   The MRI indicates a low-risk environment (0.3286).
    *   The RSI of 67.76 suggests the stock is approaching overbought conditions.
    *   The PPO is positive (0.0759), indicating a bullish trend.
    *   The hybrid signal recommends a strategic buy, allocating 90% of available cash to purchase 1030 shares while keeping a 7% cash reserve.
    *   The negative change in relative divergence (-0.5) suggests a short-term downward movement compared to the S\&P 500.
    *   The expected return is highly negative (-2182%), suggesting substantial underperformance compared to the S&P 500 over a 2+ year investment horizon.

**4. Recent News & Significant Events**

*   **Summary:** Recent news highlights volatility and discussions about Nike's performance amid industry trends and economic factors. Analysts are advising investors to monitor news and company announcements.

*   **Analysis:** The news snippets suggest that Nike is currently subject to significant market attention, with developments impacting stock volatility. Investors should be wary.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
| :--------- | :----- | :----------- |
| 2025-04-03 | 0.54 | 11.27 B$   |
| 2025-01-03 | 0.78 | 12.35 B$   |
| 2024-10-07 | 0.7  | 11.59 B$   |
| 2024-04-04 | 0.77 | 12.43 B$   |
| 2025-04-03 | 0.77 | 12.43 B$   |

*   **Analysis:**
    *   EPS: Fluctuates throughout the quarters, with some volatility in earnings. Recent quarter shows a lower EPS than previous.
    *   Revenue: Similar to EPS, revenue varies. Recent quarters revenue is showing lower results.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-05-31 | $11.10B  | 40.27%       |
| 2025-02-28 | $11.27B  | 41.49%       |
| 2024-11-30 | $12.35B  | 43.62%       |
| 2024-08-31 | $11.59B  | 45.36%       |
| 2024-05-31 | $12.61B  | 44.69%       |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
| :----------- | :-------- | :----- |
| 2025-05-31 | $13.21B  | 1.60%  |
| 2025-02-28 | $14.01B  | 5.67%  |
| 2024-11-30 | $14.04B  | 8.29%  |
| 2024-08-31 | $13.94B  | 7.54%  |
| 2024-05-31 | $14.43B  | 10.40% |

*   **Analysis:**
    *   Revenue: Decreasing trend in recent quarters.
    *   Profit Margin: Decreasing trend, indicating eroding profitability.
    *   Equity: Stable but decreased in the most recent quarter.
    *   ROE: Decreasing trend, indicating lower returns on equity.

**7. Overall Analysis**

Nike (NKE) is showing mixed signals. While there's been a recent price increase, the stock has significantly underperformed the S&P 500. Financial metrics like revenue, profit margins, and ROE show a concerning downward trend. While the MRI suggests low market risk, the expected return is highly negative, indicating potential long-term underperformance relative to the market.
Recent news highlights volatility and ongoing discussions about Nike's performance. The hybrid signal suggests a strategic buying opportunity, allocating 90% of available cash to purchase 1030 shares while keeping a 7% cash reserve.

**Recommendation:** Based on the data, a cautious approach is warranted. Investors should closely monitor Nike's upcoming earnings reports, news, and industry developments to assess the potential for a turnaround.
